Pfizer Products Inc.
Records under this name other than the patents Pfizer Products Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,257,739 | Pharmaceutical Compositions of Semi-Ordered Drugs and Polymers now held by Lonza Bend Inc. In force · High confidence | In force | High confidence | |
| US 11,524,067 | Methods of Vaccine Administration now held by Zoetis LLC In force · High confidence | In force | High confidence | |
| US 11,524,068 | Methods Of Vaccine Administration now held by Zoetis Services LLC In force · High confidence | In force | High confidence | |
| US 9,211,261 | Immediate Release Dosage Forms Containing Solid Drug Dispersions now held by Lonza Bend Inc. In force · Medium confidence | In force | Medium confidence | |
| US 12,290,559 | Methods Of Vaccine Administration now held by Zoetis Services LLC In force · High confidence | In force | High confidence | |
| US 8,440,822 | Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth now held by Pfizer, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 7,692,038 | Crystalline Forms now held by Conatus Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 9,545,384 | Nanoparticles Comprising Drug, a Non-Ionizable Cellulosic Polymer and Tocopheryl Polyethylene Glocol Succinate now held by Lonza Bend Inc. In force · High confidence | In force | High confidence | |
| US 8,703,199 | Pharmaceutical Compositions of Adsorbates of Amorphous Drug held by Bend Research, Inc. Lapsed on the fee record Ended Apr 22, 2026 · Low confidence | Lapsed on the fee record | Ended Apr 22, 2026 | Low confidence |
| US 7,473,787 | Bicyclic [3.1.0] Derivatives as Glycine Transporter Inhibitors held by Pfizer, Inc. and Pfizer Products, Inc. Term ended Term ended Oct 21, 2025 · High confidence | Term ended | Term ended Oct 21, 2025 | High confidence |